Sigma Healthcare Limited
SIG
Rangering i aksjer
#1046
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Aksjekurs
$1.95
Markedsverdi
$22.39B
Endring (1 dag)
-0.18%
Endring (1 år)
-1.35%
Land
AU
Handel Sigma Healthcare Limited (SIG)
Kategori
Healthcare
Inntekter for Sigma Healthcare Limited (SIG)
Inntekter i Jun 2026 TTM: $708.86M
Ifølge Sigma Healthcare Limited sine nyeste økonomiske rapporter er selskapets nåværende resultat $708.86M. I 2024 hadde selskapet et resultat på $5.66M, en økning sammenlignet med resultatet i 2023, som var $3.85M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Sigma Healthcare Limited fra 2001 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $708.86M | 10,096.86% |
| 2025 | $6.95M | 22.78% |
| 2024 | $5.66M | 47.02% |
| 2023 | $3.85M | -165.59% |
| 2022 | $-5.87M | -126.98% |
| 2021 | $21.76M | -306.27% |
| 2020 | $-10.55M | -127.92% |
| 2019 | $37.78M | -40.47% |
| 2018 | $63.46M | 9.21% |
| 2017 | $58.11M | 6.92% |
| 2016 | $54.35M | -7.44% |
| 2015 | $58.71M | -1.86% |
| 2014 | $59.82M | 130.12% |
| 2013 | $26.00M | -65.98% |
| 2012 | $76.42M | -187.31% |
| 2011 | $-87.53M | -67.44% |
| 2010 | $-268.78M | -435.64% |
| 2009 | $80.08M | -18.27% |
| 2008 | $97.98M | -5.93% |
| 2007 | $104.16M | 37.29% |
| 2006 | $75.87M | 249.98% |
| 2004 | $21.68M | 59.62% |
| 2003 | $13.58M | 86.27% |
| 2002 | $7.29M | 86.95% |
| 2001 | $3.90M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $6.46B | 811.04% |
US
|
|
| - | - |
US
|
|
| $2.17B | 206.69% |
US
|
|
| - | - |
US
|
|
| $558.00M | -21.28% |
US
|
